Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps he is taking to reduce the number of attacks on ambulance workers in (a) England, (b) the North West and (c) Lancashire.
Answered by Philip Dunne
National Health Service staff work very hard in a high pressure environment. Any abuse of staff is unacceptable and should not be tolerated. Employers in the NHS are responsible for assessing risks to staff and addressing those risks.
Any abuse against members of NHS staff should be reported and trusts should have no hesitation in involving the police. Detailed guidance is available to NHS employers to assist them in assessing and managing the risks accordingly. Guidance includes advice on joint working between the NHS, the police and the Crown Prosecution Service on responses to incidents of abuse or violence when these occur and on taking forward appropriate cases for prosecution.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate has been made of the number of public-access defibrillators in (a) Pendle, (b) Lancashire and (c) the North West.
Answered by David Mowat
The Department does not hold figures on this. However, the British Heart Foundation was awarded £1 million by the Department in both 2015/16 and 2016/17 to invest in public access defibrillators.
NHS England’s National Clinical Director for Cardiovascular Disease Prevention is supporting the British Heart Foundation in its work to identify the location of public access defibrillators. The aim is to establish a national database and to make this available to ambulance services.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he has made of the adequacy of availability of naloxone to treat drug-related disorders in (a) England, (b) the North West and (c) Lancashire.
Answered by Baroness Blackwood of North Oxford
Local authorities are responsible for assessing local need and commissioning substance misuse services, to meet that need. Naloxone provision is commissioned by local authority public health commissioners, working in partnership with local health commissioners. Public Health England (PHE) supports local authorities in this work and has provided advice on naloxone provision to commissioners.
Following the report of the PHE inquiry into drug-related deaths in 2016
http://www.nta.nhs.uk/uploads/phe-understanding-preventing-drds.pdf
work has continued on a programme of activity to map the provision of naloxone in England and support greater consistency in its provision and funding.
PHE North West Centre is supporting this work including consultations with drug treatment service commissioners and providers in the North West, including Lancashire, to identify how naloxone is being provided and how we might improve its availability.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what representations he has received on trends in the number of deaths from illegal drug use; and if he will make a statement.
Answered by Baroness Blackwood of North Oxford
A small number of written representations have been received on trends in the number of deaths from illegal drug use.
The Government is concerned at the rises in drug-related deaths and is taking action to prevent avoidable deaths. Public Health England (PHE) supports effective drug treatment in the community and in custody, which is known to reduce drug deaths. The Government has changed legislation to enable the easier distribution of naloxone, which is a safe, efficacious drug for reversing the effects of opioid overdoses. The Department has introduced a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas to benchmark their performance against others.
Following the report of the PHE supported inquiry into drug-related deaths in 2016, PHE and the Department are helping local authorities improve their drug-related death review processes, supporting an update to the United Kingdom-wide clinical guidelines for drug treatment, improving the sharing of intelligence on the adverse health effects of drugs, especially novel psychoactive substances, and working with treatment providers to develop guidance on how they manage risk factors associated with drug-related deaths.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to reduce the number of deaths from illegal drug use.
Answered by Baroness Blackwood of North Oxford
A small number of written representations have been received on trends in the number of deaths from illegal drug use.
The Government is concerned at the rises in drug-related deaths and is taking action to prevent avoidable deaths. Public Health England (PHE) supports effective drug treatment in the community and in custody, which is known to reduce drug deaths. The Government has changed legislation to enable the easier distribution of naloxone, which is a safe, efficacious drug for reversing the effects of opioid overdoses. The Department has introduced a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas to benchmark their performance against others.
Following the report of the PHE supported inquiry into drug-related deaths in 2016, PHE and the Department are helping local authorities improve their drug-related death review processes, supporting an update to the United Kingdom-wide clinical guidelines for drug treatment, improving the sharing of intelligence on the adverse health effects of drugs, especially novel psychoactive substances, and working with treatment providers to develop guidance on how they manage risk factors associated with drug-related deaths.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether any NHS bodies offer advice to parents that electrical safety socket covers or inserts should be installed in the home.
Answered by Philip Dunne
On 30 June 2016 the Department issued an Estates and Facilities Alert (EFA) 2016/002 advising that electrical socket inserts should be removed from all premises where National Health Service care is delivered. The alert also advises NHS organisations against providing electrical socket inserts for use in the home. The safety Alert can be found at the following link:
https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102494
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many people have entered the Improving Access to Psychological Therapies Programme in (a) England, (b) the North West and (c) East Lancashire in each of the last three years.
Answered by Baroness Blackwood of North Oxford
The table provides figures for the number of referrals entering Improving Access to Psychological Therapies (IAPT) treatment by clinical commissioning group (CCG), England, 2012-13, 2013-14, and 2014-15.
England |
|
|
|
| |
| Number of referrals entering treatment | ||||
CCG Code | CCG Name | 2012-13 | 2013-14 | 2014-15 | |
| All England | 434,247 | 709,117 | 815,665 | |
00C | NHS Darlington CCG | 1,015 | 1,360 | 1,310 | |
00D | NHS Durham Dales, Easington and Sedgefield CCG | 2,834 | 3,470 | 3,420 | |
00F | NHS Gateshead CCG | 3,075 | 3,735 | 4,200 | |
00G | NHS Newcastle North and East CCG | 1,370 | 3,525 | 3,400 | |
00H | NHS Newcastle West CCG | 1,122 | 2,610 | 2,485 | |
00J | NHS North Durham CCG | 2,829 | 3,190 | 3,285 | |
00K | NHS Hartlepool and Stockton-On-Tees CCG | 2,837 | 7,050 | 5,605 | |
00L | NHS Northumberland CCG | 4,541 | 6,800 | 6,410 | |
00M | NHS South Tees CCG | 3,339 | 5,820 | 4,650 | |
00N | NHS South Tyneside CCG | 2,060 | 3,050 | 3,655 | |
00P | NHS Sunderland CCG | 1,312 | 5,220 | 5,615 | |
00Q | NHS Blackburn with Darwen CCG | 1,098 | 1,280 | 3,305 | |
00R | NHS Blackpool CCG | 268 | 1,730 | 2,340 | |
00T | NHS Bolton CCG | 11 | 4,760 | 5,690 | |
00V | NHS Bury CCG | 1,710 | 3,070 | 4,220 | |
00W | NHS Central Manchester CCG | 1,269 | 1,750 | 1,960 | |
00X | NHS Chorley and South Ribble CCG | 1,816 | 2,225 | 3,200 | |
00Y | NHS Oldham CCG | 564 | 2,330 | 3,760 | |
01A | NHS East Lancashire CCG | 3,420 | 3,495 | 6,980 | |
01C | NHS Eastern Cheshire CCG | 1,093 | 1,985 | 1,965 | |
01D | NHS Heywood, Middleton and Rochdale CCG | 1,156 | 3,280 | 4,425 | |
01E | NHS Greater Preston CCG | 3,096 | 2,260 | 3,960 | |
01F | NHS Halton CCG | 572 | 750 | 1,455 | |
01G | NHS Salford CCG | 1,767 | 5,255 | 6,930 | |
01H | NHS Cumbria CCG | 8,441 | 8,690 | 7,260 | |
01J | NHS Knowsley CCG | 861 | 1,915 | 2,575 | |
01K | NHS Lancashire North CCG | 1,511 | 1,505 | 3,030 | |
01M | NHS North Manchester CCG | 786 | 1,465 | 1,720 | |
01N | NHS South Manchester CCG | 1,392 | 1,660 | 1,825 | |
01R | NHS South Cheshire CCG | 1,158 | 2,085 | 1,920 | |
01T | NHS South Sefton CCG | 1,630 | 2,170 | 3,185 | |
01V | NHS Southport And Formby CCG | 1,130 | 1,490 | 2,100 | |
01W | NHS Stockport CCG | 1,274 | 2,330 | 5,290 | |
01X | NHS St Helens CCG | 990 | 1,070 | 1,885 | |
01Y | NHS Tameside and Glossop CCG | 970 | 2,045 | 5,505 | |
02A | NHS Trafford CCG | 3,182 | 3,840 | 4,405 | |
02D | NHS Vale Royal CCG | 755 | 1,375 | 1,255 | |
02E | NHS Warrington CCG | 694 | 3,250 | 3,265 | |
02F | NHS West Cheshire CCG | 4,803 | 4,350 | 4,515 | |
02G | NHS West Lancashire CCG | 1,454 | 1,635 | 2,155 | |
02H | NHS Wigan Borough CCG | 3,536 | 6,020 | 3,990 | |
02M | NHS Fylde and Wyre CCG | 1,534 | 1,510 | 2,550 | |
12F | NHS Wirral CCG | 3,323 | 4,080 | 5,410 | |
99A | NHS Liverpool CCG | 6,684 | 8,115 | 9,420 | |
99C | NHS North Tyneside CCG | 0 | 5,015 | 3,810 | |
Data source: IAPT, Health and Social Care Information Centre (HSCIC)
Notes:
1. A referral is classified as having entered treatment if it has a first, attended treatment appointment in the year.
2. For 2012-13, referrals entering treatment is a subset of referrals received in the year, as this was the first year of the IAPT programme.
3. For 2014-15, CCG is the recorded commissioner, unless this was not recorded or not a CCG, in which case the CCG is derived from the patient’s general practitioner (GP) practice or postcode. For 2013-14 and 2012-13, CCG is based on GP Practice. Where CCG and GP Practice were not recorded and could not be assigned, the referral is categorised as 'Unknown'. A list of valid CCGs can be found on the HSCIC website at:
http://systems.hscic.gov.uk/data/ods/datadownloads/othernhs
4. For this response, we are defining North West and East Lancashire as those CCGs within the following NHS Health Authority regions: Q74 - NHS England North (Cumbria and North East), Q75 - NHS England North (Cheshire and Merseyside), Q83 - NHS England North (Greater Manchester), Q84 - NHS England North (Lancashire).
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to improve community-based eating disorder services in East Lancashire.
Answered by Baroness Blackwood of North Oxford
The provision of local health services is a matter for the local National Health Service.
The Lancashire Children and Young People’s Resilience, Emotional Wellbeing and Mental Health Transformation Plan 2015-2020 sets out plans for improvements to services, including eating disorder services. The Plan can be accessed using the following link:
http://www.blackburnwithdarwenccg.nhs.uk/health/child-health/camhs/
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much the NHS spent on Lyme disease laboratory tests in each of the last three years.
Answered by Jane Ellison
As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.
The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.
Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.
There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to ensure that new guidelines on the recognition and treatment of Lyme disease are made available by July 2018.
Answered by Jane Ellison
As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.
The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.
Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.
There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.